At Creative Biolabs, we provide a definitive solution to one of the most persistent hurdles in bioprocessing: lipopolysaccharide (LPS) contamination. Endotoxins are highly resilient, heat-stable molecules that can compromise the validity of in vitro assays and cause life-threatening inflammatory responses in vivo. Our service is engineered to deliver pharmaceutical-grade purity for sensitive biologics, ensuring that your research is based on the true biological activity of the target molecule rather than the artifacts of contamination.
The extraction assay for endotoxin removal is a specialized biochemical process that exploits the hydrophobic properties of lipid A to separate it from hydrophilic target molecules. Peer-reviewed scientific reports underscore that liquid-liquid partitioning, particularly using Triton X-114, is highly effective for reducing endotoxins in protein and phage preparations. Creative Biolabs utilizes these scientifically validated principles alongside patented affinity ligands to achieve near-absolute purity, ensuring that therapeutic candidates are free from pyrogenic interference and ready for advanced preclinical evaluation.
Creative Biolabs offers high-performance phase-partitioning solutions designed to maximize endotoxin depletion while ensuring the structural integrity and high recovery of your therapeutic proteins and bacteriophages.
We utilize optimized Triton X-114 and 1-octanol extraction protocols to achieve a 1000-fold reduction in endotoxin levels, ensuring your biological samples meet the most stringent pharmaceutical purity standards for clinical applications.
Our patented Miro2p12 technology enables high-efficiency endotoxin removal in standard PBS and citrate buffers without requiring bivalent cations, preventing the common issue of sensitive protein aggregation during the purification process.
We implement rigorous secondary purification steps using bio-beads SM-4 and gel filtration to reduce residual surfactants to below 0.01%, guaranteeing that your final product is non-cytotoxic and safe.
Every project includes rigorous quantification using kinetic chromogenic LAL or MAT assays, accompanied by a detailed technical data package documenting log-reduction, protein recovery rates, and residual solvent analysis.
Discover How Creative Biolabs Can Secure Your Data Integrity – Request a Consultation
Our standardized workflow ensures a seamless transition from sample reception to final formulation, supported by rigorous quality control and technical documentation at every stage.
Creative Biolabs stands at the forefront of endotoxin mitigation, combining proprietary technologies with decades of chromatographic expertise. Our unique advantage lies in our ability to handle complex biological matrices that traditional chromatography methods often fail to purify effectively. According to "published data," our extraction protocols achieve a consistent 3-log (1000-fold) reduction in endotoxin levels with minimal protein loss (often <5%), which is essential for preserving high-value recombinant leads. Unlike generic services, we utilize ion-independent technologies that facilitate purification in standard PBS and citrate buffers. This prevents the aggregation of sensitive proteins that occurs when bivalent ions are required. Creative Biolabs ensures that your lead optimization is never compromised by the structural alterations often associated with harsh purification methods.
Experience the Creative Biolabs Advantage – Get a Technical Quote Today
Creative Biolabs primarily uses non-ionic surfactants like Triton X-114, which are specifically chosen for their gentle, non-denaturing properties. Our protocols are optimized to maintain the native conformation and biological activity of your target throughout the phase separation process.
Yes. We offer specialized 1-octanol and Miro2p12 extraction protocols specifically optimized for phage lysates, which effectively remove LPS from phage tail proteins while maintaining high viral titers.
Absolutely. Our patented ion-independent technology allows for high-efficiency extraction in standard PBS and Citrate buffers, eliminating the need for bivalent cations that might interfere with your sample's stability.
To ensure the success of your broader development goals, Creative Biolabs recommends the following complementary services:
Creative Biolabs provides lipid kinase panel screening to evaluate compound interactions. We deliver high-quality, reproducible data across a broad enzyme spectrum to accelerate drug discovery and target validation.
Learn More →Creative Biolabs utilizes advanced algorithms to identify antibody PTM liabilities. We mitigate risks by predicting sequence-based instabilities, ensuring superior affinity, stability, and production quality.
Learn More →Creative Biolabs provides a world-class extraction assay, utilizing patented ion-independent technology and optimized phase-separation protocols. We empower researchers to overcome the challenges of LPS contamination, ensuring high recovery, superior purity, and preclinical-grade safety for all biological products.
For detailed inquiries, customized protocols, or to discuss your specific project requirements with our senior scientists, please reach out to us.